Latest news Latest news Latest news

Latest news

Corporate

Disclosure pursuant to article 15 of the Transparency Act of 2 May 2007 – new denominator following the capital increase

11/02/2025 - 09:00

Corporate

Final results of the capital increase

07/02/2025 - 13:00

Corporate

Take-up of 82.5% of the New Shares offered for subscription through exercise of Preferential Rights in the context of the capital increase & launch of accelerated private placement of Scrips

07/02/2025 - 09:00

Portfolio

K&F group groeit vanaf nu verder binnen de Fronnt groep

03/02/2025 - 10:01

Portfolio

Gimv invests in RoboJob, leader in CNC Automation, and teams up with the De Roovere family

03/02/2025 - 07:30

Portfolio

Kinaset Therapeutics Announces FDA Clearance of IND Application for frevecitinib (KN-002) in Asthma Treatment

30/01/2025 - 09:28

Corporate

Gimv launches strategy to accelerate its growth

22/01/2025 - 07:04

Corporate

Aankondiging door Gimv NV overeenkomstig artikel 7:189, lid 2 van het Wetboek van vennootschappen en verenigingen

15/01/2025 - 07:23

Corporate

Report of the Extraordinary General Shareholders’ Meeting

13/01/2025 - 17:45

Portfolio

Mediar Therapeutics Enters into Global Licensing Agreement with Lilly to Advance First-in-Class WISP1 Antibody for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)

10/01/2025 - 15:45

Portfolio

FIRE1 Secures $120 Million Financing to Revolutionize Heart Failure Care

07/01/2025 - 09:05

Corporate

Report of the Extraordinary General Shareholders’ Meeting

23/12/2024 - 17:45

Contact information

Investor Relations

Do you have any questions or require more information? Please contact us.